News

  • Analysing multiple mammograms improves breast cancer risk prediction

    A new study describes an innovative method of analysing mammograms that significantly improves the accuracy of predicting the risk of breast cancer development over the following five years. Using up to three years of previous mammograms, the new method identified individuals at high risk of developing breast cancer 2.3 times more accurately than the standard [...]

  • Feminist mothers may be compromising children’s sex education at home, study finds

    Parents don't need to be blamed or shamed when providing sex education to their children, they need better support to help them safely parent their children in an increasingly complicated, digital world without compromising their values, researchers have said. In a new study, researchers found that self-identified feminist mothers across England unintendedly compromised their values [...]

  • Newborn screening by genome sequencing shown to be safe and effective

    Two studies show the potential for genomic screening in newborns to address high rates of infant hospitalisation and mortality. Presently, hundreds of genetic diseases are either preventable or treatable but currently are detected only after a child falls ill and endures a years-long “diagnostic odyssey,” often receiving diagnoses too late to achieve the best outcomes. [...]

  • Imaging technique allows rapid assessment of ovarian cancer

    An MRI-based imaging technique can predict the response of ovarian cancer tumours to treatment and rapidly reveals how well treatment is working in patient-derived cell models. The technique, called hyperpolarised carbon-13 imaging, can increase the detected signal in an MRI scanner by more than 10,000 times. Scientists have found that the technique can distinguish between [...]

  • Maternal health company Nua Surgical secures €6.5m for C-Section retractor

    Nua Surgical, an Irish medical device company focusing on maternal health has secured €6.5m that will be used to drive the manufacturing, testing, regulatory clearance and early commercialisation of its C-Section retractor. The device has been designed to address the unique challenges of C-Section surgery. Caesarean sections are the most common major surgical procedure globally, [...]

  • Clinical trial of device aims to induce ovulation in women with polycystic ovary syndrome

    Physicians are leading a national clinical trial to help women with polycystic ovary syndrome (PCOS)-related infertility who want to become pregnant. The trial, called REBALANCE, studies the safety and effectiveness of an investigational device developed by May Health that is designed to restore ovulation disrupted by PCOS. OU Health reproductive endocrinologist Karl Hansen, M.D., Ph.D., [...]

  • Women pay for AI to boost mammogram findings

    More than a third of women across 10 health care practices in the US chose to enrol in a self-pay, artificial intelligence (AI)-enhanced breast cancer screening programme, and the women who enrolled were 21 per cent more likely to have cancer detected, according to new research. AI has shown great promise in mammography as a [...]

  • $2.5m grant to support development of novel contraceptive technology

    Women's health company Daré Bioscience has recieved a $2.5m grant  to advance the development of its investigational contraceptive DARE-LARC1 through non-clinical proof of principle studies and other IND-enabling work. DARE-LARC1 is a potential new category of long-acting, reversible contraceptive (LARC). If successfully developed and approved, DARE-LARC1 could provide women with a higher level of control [...]

  • Unlocking new potential in stem cell-based embryo models

    Researchers have identified Nr1h2, a critical transcription factor essential for early embryo development. The findings enhance our understanding of gene regulation during blastoid formation and hold promise for regenerative medicine, fertility treatments, and developmental biology research. At the earliest stages of life, the blastocyst—a highly organised structure critical for implantation—begins to form. Its development is [...]

  • New mammography system designed to enhance screening unveiled

    A new mammography system has been unveiled which has been designed to provide mammography technologists with a suite of tools that balance the demands of diagnostic accuracy and fast-paced workflows to facilitate more patient-centred breast care. Developed by GE HealthCare, the Pristina Via mammography system aims to minimise repetitive tasks and streamline workflows so that [...]